Collplant CLGN 深 沪
等待开盘 11-11 09:30:00 美东时间
3.905
-0.385
-8.97%
华盛通- 最 高4.15
- 今 开4.15
- 成交量 2.21万股
- 最 低 3.86
- 昨 收 4.29
- 总市值 1201.01万
- 52周最高 22.50
- 市盈率 静 --
- 换手率 0.72%
- 52周最低 2.637
- 委 比 81.82%
- 总股本 307.56万
- 历史最高 242.60
- 量 比 0.52
- 振 幅 6.76%
- 历史最低 2.637
- 每 手 1
- 风险率 6.01%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多CollPlant’s LightSolver Secures $1.8 Million Israeli Innovation Grant
An update from Collplant Holdings ( ($CLGN) ) is now available. CollPlant Biote...
11-05 22:28
Reported Earlier: CollPlant Subsidiary LightSolver Signs Multi-Year Israel Defense Ministry Agreement For Photonic Computing, Secures Initial 12-Month Order In Defense Market With Estimated $5B Annual TAM, 15% CAGR
CollPlant Biotechnologies Ltd. (NASDAQ:CLGN) today announced that its subsidiary LightSolver Ltd. ("LightSolver"), a pioneer of pure photonic computing and developer of the Laser Processing Unit (LPU)™, has signed an agreement with the Directorate of Defense Research & Development (DDR&D) within the...
10-30 00:10
LightSolver Secures Paid Collaboration with the Israel Ministry of Defense for the Development of Photonic Computing Technology
LightSolver, a subsidiary of CollPlant Biotechnologies, has signed a multi-year agreement with Israel's Ministry of Defense to develop and deliver its Laser Processing Unit (LPU) for advanced defense applications. This collaboration underscores LightSolver's position in the emerging photonic computing market, estimated at up to $5 billion annually. The LPU, designed for complex, high-dimensional computations, offers faster solutions and lower pow...
10-29 12:00
CollPlant Raises $3.7 Million to Accelerate LightSolver Laser Supercomputing
An announcement from Collplant Holdings ( ($CLGN) ) is now available. On Octobe...
10-10 05:47
COLLPLANT ANNOUNCES A $3.7 MILLION PRIVATE PLACEMENT
Transaction Led Primarily by Existing Investors to Accelerate LightSolver's Laser-Based Supercomputing Development REHOVOT, Israel, Oct. 9, 2026 /PRNewswire/ -- CollPlant Biotechnologies (Na...
10-09 21:00
CollPlant Biotechnologies Q2 Adj. EPS $(1.69) Misses $(0.24) Estimate, Sales $108.000K Miss $1.466M Estimate
CollPlant Biotechnologies (NASDAQ:CLGN) reported quarterly losses of $(1.69) per share which missed the analyst consensus estimate of $(0.24) by 604.17 percent. This is a 26.52 percent increase over losses of $(2.30) per share from the same period last year. The company reported quarterly sales of $...
10-01 05:33
CollPlant Announces Publication Of Joint Research Conducted By Its Subsidiary LightSolver Showing Photonic Computing Advantage Over GPUs
Peer-reviewed study published by ACM: LightSolver's LPU architecture demonstrated significantly lower projected time-to-solution, compared to state-of-the-art algorithms running on a GPU REHOVOT, Israel, September 24, 2026 /PRNewswire/ -- CollPlant Biotechnologies Ltd. (NASDAQ:CLGN) today announced ...
09-24 20:07
CollPlant regains Nasdaq compliance
CollPlant (CLGN) said on Tuesday it regained compliance with Nasdaq’s $1 minimum bid price requirement under Listing Rule 5550(a)(2). The shares maintained a closing bid price above the threshold for ...
09-22 19:46
CollPlant Biotechnologies Board Approves 1-For-10 Reverse Share Split, Effective September 4
CollPlant Biotechnologies Ltd. (NASDAQ:CLGN) ("CollPlant" or the "Company"), today announced that its Board of Directors has approved a one-for-ten reverse share split of the Company's ordinary shares. The reverse share split is scheduled to take effect when the Nasdaq Capital Market opens on Septem...
09-02 04:03
COLLPLANT ANNOUNCES REVERSE SHARE SPLIT
REHOVOT, Israel, Sept. 1, 2026 /PRNewswire/ -- CollPlant Biotechnologies Ltd. (Nasdaq: CLGN) ("CollPlant" or the "Company"), today announced that its Board of Directors has approved a one-fo...
09-02 04:01
